Search for: "Martin v. General Finance Co." Results 21 - 40 of 85
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 May 2008, 1:03 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Indian Patent Office decisions now searchable and downloadable: (Indian Patent Oppositions), (Generic Pharmaceuticals & IP), (Spicy IP), Institute for Progress study on inter partes re-examination: (Peter Zura's 271 Patent Blog), (IAM), (Hal Wegner) Nintendo loses patent suit over 3D controller; Anascape awarded $21M in damages:… [read post]
23 Sep 2018, 9:50 am by Wolfgang Demino
The Borrowers asserted causes of action for malicious prosecution, fraud, and violations of the Deceptive Trade Practices Act, Consumer Protection Act, and the Finance Code. [read post]
1 Dec 2023, 3:00 am by Jim Sedor
Christopher Kurka allowed Pat Martin, head of Alaska Right to Life, to use their offices for several hours when Martin traveled from Wasilla to the state Capitol “with the stated intent to distribute signed petitions to the Legislature. [read post]
14 Jun 2020, 4:27 pm by INFORRM
Global Banking & Finance Review had a piece “Harnessing blockchain to revamp the data privacy landscape”. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
9 Aug 2008, 1:50 am
: (Patenting Lives), Worldwide increase in patent filings puts strain on system: (Managing Intellectual Property), WIPO releases 2008 Worldwide Patent Report: (Peter Zura's 271 Patent Blog), (Patent Prospector), (IP Updates), Global patent filings continue rise but may level off; smaller nationals slipping: (Intellectual Property Watch), Means plus function: Don’t ignore the man behind the curtain: (Intellectual Property Directions), Technology start-up entrepreneurs and CEOs: If your… [read post]
3 Dec 2009, 12:13 am
They've cited, most recently, the Court's 5-4 decision this year in Ashcroft v. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC)   Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent… [read post]
26 Mar 2018, 6:09 pm by Wolfgang Demino
The Borrowers asserted causes of action for malicious prosecution, fraud, and violations of the Deceptive Trade Practices Act, Consumer Protection Act, and the Finance Code. [read post]
14 Apr 2013, 4:00 am by Administrator
Bankruptcy & Insolvency: PensionsSun Indalex Finance, LLC v. [read post]
4 Apr 2008, 1:00 am
, (Ars Technica), (Patent Prospector), (Washington State Patent Law Blog), (IP Law Observer), (PLI), (PLI), (IP Updates), (Patent Docs), (Peter Zura’s 271 Patent Blog), (The Invent Blog), (IP Spotlight), (Just a Patent Examiner), (Techdirt), (Patent Baristas), (IPBiz), (IPBiz), (Patently-O), (IAM), (IP ThinkTank), (Against Monopoly), (Against Monopoly), (IP Law360), (Hal Wegner), (Ladas & Parry), Global Global - General Virtual monopoly – four strategic… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the importation of… [read post]
28 Jan 2023, 7:32 am
Greater comparability of climate transition methodologies, as well as transparency and interpretability of climate finance and ESG metrics are urgently needed. [read post]